Is Adderall legal in United Arab Emirates?

Also known as: addy, amphetamine salts

Legal status

Adderall is a brand and not a schedule heading, so Decision No. 158 of 2025 does not carry it as such. The dossier resolves the row through the product's content, recording the entry as «أمفيتامين؛ أملاح الأمفيتامين في Adderall»: the mixed amphetamine salts place a genuine product in the amphetamine regime, which in this instrument is Schedule 6. The consequence is that the placement follows the active ingredient rather than the label, so a prescription naming the brand is describing a Schedule 6 substance whether or not the schedule uses the brand word anywhere. The row runs through Articles 11, 43 and 58, with Schedule 10 carrying the quantity bands. The placement was read on 20 September 2026.

Consequences if caught

Article 58 reaches Schedules 3, 6, 7 and 8, and the amphetamine content places this row in Schedule 6, so the article applies through the constituent rather than through a brand entry. The dossier records Article 58 as providing death or life imprisonment as alternatives for its stated trafficking or promotion trigger, so death is discretionary here and not mandatory, and it records that the article states no quantity. The Schedule 10 bands do not gate that route. The combination that catches people on this row is a lawfully prescribed stimulant meeting a capital trafficking article, where the supply act most likely to arise is sharing tablets with someone else rather than anything a reader would call trafficking. Article 43 carries the personal use route for this branch, with its tariff unstated.

If prescribed or medical

The dossier records at the modafinil row that a 268 entry ministry travellers list was checked and expressly not used as a schedule. Attached to this substance: the product is placed through its amphetamine content in Schedule 6, and the dossier records no prescribing route, traveller allowance or import permit procedure for that branch. This is the row where the gap bites hardest, because the medicine is prescribed routinely to people who travel, and the dossier does not record what an Emirati authorisation would require. The question is deferred rather than answered.

Documentation

Carry the prescription naming the active ingredient rather than only the brand, with the original dispensing packaging and a physician's letter, and settle the permit question with the health ministry before travelling, because no Emirati permit procedure is recorded in this dossier. Provenance: the placement through amphetamine content and the entry «أمفيتامين؛ أملاح الأمفيتامين في Adderall» were read on 20 September 2026, with the capital analysis resting on Article 58 and its death or life alternative. A brand name alone does not disclose what is in the box, and it is the content that the schedule reaches.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with United Arab Emirates’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.